114 related articles for article (PubMed ID: 19076698)
1. Lymphatic phenotype of tumour vessels in malignant gliomas.
Grau SJ; Trillsch F; von Lüttichau I; Nelson PJ; Herms J; Tonn JC; Goldbrunner RH
Neuropathol Appl Neurobiol; 2008 Dec; 34(6):675-9. PubMed ID: 19076698
[No Abstract] [Full Text] [Related]
2. Increased levels of tissue endostatin in human malignant gliomas.
Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
[TBL] [Abstract][Full Text] [Related]
3. Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis.
Asgari S; Röhrborn HJ; Engelhorn T; Stolke D
Acta Neurochir (Wien); 2003 Jun; 145(6):453-59; discussion 459-60. PubMed ID: 12836069
[TBL] [Abstract][Full Text] [Related]
4. Tubular bodies (Weibel-Palade bodies) in endothelial cells of glioblastomas and astrocytomas.
Miyagami M; Nakamura S
Noshuyo Byori; 1996 Nov; 13(2):107-13. PubMed ID: 8958515
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in brain tumors.
Lopes MB
Microsc Res Tech; 2003 Feb; 60(2):225-30. PubMed ID: 12539176
[TBL] [Abstract][Full Text] [Related]
6. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
Bian XW; Jiang XF; Chen JH; Bai JS; Dai C; Wang QL; Lu JY; Zhao W; Xin R; Liu MY; Shi JQ; Wang JM
Int Immunopharmacol; 2006 Jan; 6(1):90-9. PubMed ID: 16332517
[TBL] [Abstract][Full Text] [Related]
7. Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1.
Di X; Nishizaki T; Harada K; Kajiwara K; Nakayama H; Ito H
J Exp Clin Cancer Res; 1997 Jun; 16(2):153-7. PubMed ID: 9261740
[TBL] [Abstract][Full Text] [Related]
8. Morphological aspects of the vessels of brain tumours.
Solé-Llenas J; Mercader JM; Pons-Tortella E
Neuroradiology; 1977 Mar; 13(1):51-4. PubMed ID: 191767
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines.
Husain N; Chiocca EA; Rainov N; Louis DN; Zervas NT
Acta Neuropathol; 1998 Mar; 95(3):287-90. PubMed ID: 9542594
[TBL] [Abstract][Full Text] [Related]
10. VCAM-1 expression on reactive and tumour astrocytes.
Kałuza J; Krupiński J; Kumar P; Kumar S; Wang JM
Folia Histochem Cytobiol; 1994; 32(1):17-20. PubMed ID: 7517897
[TBL] [Abstract][Full Text] [Related]
11. Assessment of protein conformation in human benign and malignant astrocytomas by reflectance Fourier transform infrared microspectroscopy.
Lee LS; Chi CW; Liu HC; Cheng CL; Li MJ; Lin SY
Oncol Res; 1998; 10(1):23-7. PubMed ID: 9613454
[TBL] [Abstract][Full Text] [Related]
12. Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans.
Schley M; Ständer S; Kerner J; Vajkoczy P; Schüpfer G; Dusch M; Schmelz M; Konrad C
Brain Res Bull; 2009 Jun; 79(5):333-7. PubMed ID: 19480992
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma.
Jang FF; Wei W; De WM
J Ayub Med Coll Abbottabad; 2008; 20(2):105-9. PubMed ID: 19385471
[TBL] [Abstract][Full Text] [Related]
14. The importance of linoleic acid in the total fatty acid compositions of benign and malignant neuroglial tumors.
Louw L; Engelbrecht AM; Cloete F; van der Westhuizen JP; Joubert G
Adv Exp Med Biol; 1997; 400B():919-24. PubMed ID: 9547647
[No Abstract] [Full Text] [Related]
15. Tenascin-C in astrocytic tumors.
Viale G; Dorcaratto A; Castellani P; Zardi L
Surg Neurol; 2002 Apr; 57(4):286; author reply 287. PubMed ID: 12173397
[No Abstract] [Full Text] [Related]
16. Giant cell glioblastoma and pleomorphic xanthoastrocytoma.
Katsetos CD; de Chadarévian JP; Legido A; Perentes E; Mörk SJ
Arch Pathol Lab Med; 2004 Apr; 128(4):391-2; author reply 392-3. PubMed ID: 15043454
[No Abstract] [Full Text] [Related]
17. Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains.
Maruno M; Yoshimine T; Isaka T; Kuroda R; Ishii H; Hayakawa T
J Neurooncol; 1994; 19(2):155-60. PubMed ID: 7964991
[TBL] [Abstract][Full Text] [Related]
18. Metallothioneins and microelements in brain tumours.
Floriańczyk B; Kaczmarczyk R; Osuchowski J; Stryjecka-Zimmer M; Trojanowski T; Marzec Z
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):1-4. PubMed ID: 15314949
[TBL] [Abstract][Full Text] [Related]
19. VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.
Petrova TV; Bono P; Holnthoner W; Chesnes J; Pytowski B; Sihto H; Laakkonen P; Heikkilä P; Joensuu H; Alitalo K
Cancer Cell; 2008 Jun; 13(6):554-6. PubMed ID: 18538738
[No Abstract] [Full Text] [Related]
20. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
